CellaVision AB Market Cap

CellaVision AB has a market cap or net worth of $399.56 million as of April 28, 2025. Its market cap has decreased by -18.98% in one year.

Market Cap

399.56M

Enterprise Value

386.92M

Revenue

65.35M

Ranking

n/a

PE Ratio

31.42

Stock Price

$19.28

Market Cap Chart

Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 399.56M, an increase of 635.15%. That is a compound annual growth rate of 11.77%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	399.56M	-14.93%
Dec 30, 2024	469.69M	-6.32%
Dec 29, 2023	501.37M	-4.32%
Dec 30, 2022	523.98M	-38.89%
Dec 30, 2021	857.50M	-4.04%
Dec 30, 2020	893.58M	9.30%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Glass House Brands	500.84M
Elite Pharmaceuticals	450.22M
Northwest Biotherapeutics	443.51M
CytoDyn	284.32M
BioStem Technologies	245.41M

Market Cap Rankings